A new review in Archives of Physiology and Biochemistry summarizes the evidence that several well-studied phytochemicals can reduce aflatoxin B1-induced injury to the intestinal lining. Aflatoxin B1 is a widely studied mycotoxin produced by Aspergillus species and is known to drive intestinal damage through oxidative stress, cytochrome P450 upregulation, lipid peroxidation, and inflammatory and apoptotic signaling.
The authors highlight curcumin, resveratrol, lycopene, melatonin, and polydatin as the most consistently studied protective agents, acting through pathways including Nrf2/ARE, TLR4, NF-kappa-B, and NLRP3, and also modulating gut microbiota composition. The review notes that direct clinical evidence in humans remains limited and calls for more translational work.
For people working through chronic gastrointestinal symptoms in the setting of suspected mycotoxin exposure, the review reinforces that the mechanisms involved are inflammatory and redox-driven, and that the same pathways implicated in biotoxin illness research are targets here.